Delivery Order SPE2DB20D6037-SPE2DB25FTUT0
Award Date
2/19/25
Potential Completion Date
2/20/25
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of 4,557,954,905 units of Naloxone hydrochloride 4 mg nasal spray. The contract has a ceiling value of $5,266.28 and an ultimate completion date of August 2, 2022. This delivery order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999, which covers a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,840.00 contract is for the delivery of 4,557,523,711 units of Naloxone Hydrochloride 4 mg Nasal Spray. The award is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA under the SPE2DB program, valued at up to $499,999,999 and running...
The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 4,563,305,475 units of Naloxone Hydrochloride Nasal Spray. The delivery order is valued at $1,922.19 and will be completed by January 12, 2024. This delivery order is part of a larger indefinite delivery contract held by DMS Pharmaceutical Group Inc. with the Defense Logistics Agency to provide various pharmaceutical and medical...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $6,393.26 to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of 4,558,189,631 units of Naloxone HCL 4 mg nasal spray. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which covers a wide range of pharmaceutical products for military health facilities...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $2,032.20 contract is for the supply of 4,559,264,470 units of the opioid overdose reversal medication NARCAN 4 mg nasal spray. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which allows the agency to...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA), under the Medical Supply Chain program, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $1,434.00, is for the delivery of Naloxone Hydrochloride, a medication used to reverse opioid overdose. The contract is part of a larger indefinite delivery contract (IDC) with a ceiling value of up to $499,999,999 that DMS Pharmaceutical Group...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $2,037.00, is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a medication used to reverse opioid overdose. The contract is part of a larger $499,999,999 indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, under the SPE2DB...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois. The $1,629.60 firm fixed-price contract is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a specialized medication used to treat opioid overdose. The contract has a performance period through March 2022 and is not associated with any set-aside designation. DMS Pharmaceutical Group Inc. holds a significant...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,358 award is for the supply of NARCAN 4 MG NASAL SPRAY 2S, a critical opioid overdose reversal medication. The award is issued under DMS Pharmaceutical Group's $499,999,999 indefinite delivery contract with the DLA's SPE2DB program, which provides a wide range of pharmaceutical...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The delivery order is for Narcan (naloxone hydrochloride) 4 milligram nasal spray, with a total potential value of $5,526.00 and a completion date of January 22, 2024. This delivery order is issued against a larger indefinite delivery contract held by DMS Pharmaceutical Group Inc. with DLA to provide various pharmaceutical and medical supplies to...